US Patent Issued to UNIVERSITY HEALTH NETWORK on May 12 for "Salt and crystal forms of 4-amino-5-(6-(4-methylpiperazin-1-yl)-1H-benzo[dimidazol-z-yl)thieno[2.3-bpyridin-6(7H)-one" (Canadian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,049, issued on May 12, was assigned to UNIVERSITY HEALTH NETWORK (Toronto).

"Salt and crystal forms of 4-amino-5-(6-(4-methylpiperazin-1-yl)-1H-benzo[dimidazol-z-yl)thieno[2.3-bpyridin-6(7H)-one" was invented by Mark R. Bray (Oakville, Canada) and Sze-Wan Li (Toronto).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel salt form of Compound (I) represented by the following structural formula, and its corresponding pharmaceutical compositions, are disclosed.Particular single crystalline forms of 1:1 Compound (I) tartrate salt are characterized by a variety of properties and physical measurements. Methods of preparing specific crystalline forms are a...